{"id":"mometasone-nasal-inhalation","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nasal irritation"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nasal congestion"},{"rate":"5-10%","effect":"Nasal dryness"},{"rate":"5-10%","effect":"Throat irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to a reduction in inflammation and swelling in the nasal passages, providing relief from symptoms of allergic rhinitis. Mometasone's mechanism of action is similar to other corticosteroids, but its potency and duration of action are unique.","oneSentence":"Mometasone is a corticosteroid that works by inhibiting the release of pro-inflammatory cytokines and mediators.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:01.354Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Chronic rhinitis"}]},"trialDetails":[{"nctId":"NCT05382494","phase":"PHASE4","title":"Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-12-05","conditions":"Sleep Disorder; Breathing-Related, Snoring, Obstructive Sleep Apnea of Child","enrollment":130},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT06573164","phase":"","title":"Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-01-01","conditions":"Rhinitis, Allergic, Asthma","enrollment":60},{"nctId":"NCT00359216","phase":"PHASE4","title":"The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Perennial Allergic Rhinitis, Obstructive Sleep Apnea, Sleep Disorder","enrollment":30},{"nctId":"NCT03451318","phase":"NA","title":"Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion","status":"UNKNOWN","sponsor":"Shanghai Stomotological Hospital","startDate":"2018-03-02","conditions":"Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Malocclusion","enrollment":400},{"nctId":"NCT02397915","phase":"PHASE4","title":"Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-03-26","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":300},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT01861145","phase":"PHASE4","title":"Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2013-05","conditions":"Enuresis, Obstructive Sleep Apnea, Sleep Disordered Breathing","enrollment":""},{"nctId":"NCT02541760","phase":"PHASE3","title":"Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children","status":"COMPLETED","sponsor":"Hormozgan University of Medical Sciences","startDate":"2014-04","conditions":"Otitis Media With Effiusion","enrollment":143},{"nctId":"NCT01287364","phase":"PHASE3","title":"Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2011-02","conditions":"Perennial Allergic Rhinitis","enrollment":185},{"nctId":"NCT01371786","phase":"PHASE1","title":"A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2011-06","conditions":"Allergic Rhinitis (AR)","enrollment":14}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nasonex®"],"phase":"phase_3","status":"active","brandName":"mometasone nasal inhalation","genericName":"mometasone nasal inhalation","companyName":"Sumitomo Pharma America, Inc.","companyId":"sumitomo-pharma-america-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone is a corticosteroid that works by inhibiting the release of pro-inflammatory cytokines and mediators. Used for Allergic rhinitis, Chronic rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}